Plasma Therapeutics Market Revenue to Attain USD 46.46 Bn by 2033

17 Jun 2025

Share :

Table of Content

1. Plasma Therapeutics Market Revenue and Trends 2025 to 2033 2. Market Overview 3. Segment Insights 4. Regional Insights 5. Plasma Therapeutics Market Coverage 6. Plasma Therapeutics Market Key Players

Plasma Therapeutics Market Revenue and Trends 2025 to 2033

The global plasma therapeutics market revenue surpass USD 28.35 billion in 2025 and is predicted to attain around USD 46.46 billion by 2033, growing at a CAGR of 6.37%. The growth of the market is attributed to the rising prevalence of chronic diseases and increasing development of new plasma-derived products. Technological advances also create opportunities in the market.

Market Overview

The plasma therapeutics market is experiencing rapid growth, driven by several factors reshaping global healthcare. The rising incidence of rare and chronic diseases, such as hemophilia and autoimmune disorders, boosts the demand for plasma-derived therapies. Technological advancements are enhancing the safety and efficacy of these therapies through new fractionation and purification methods, improving patient outcomes. Increased awareness of early diagnosis, particularly in developing economies, expands the patient base. The growing aging population further contributes to market growth, as elderly people are prone to immune disorders. Governmental initiatives, funding, and healthcare infrastructure investments support production expansion. Ongoing R&D and collaborative efforts within the biopharmaceutical sector provide impetus for innovation and growth in the plasma therapeutics market.

Segment Insights

• Based on product type, the immunoglobulin segment held the largest share of the market in 2024. Immunoglobulin is widely used to treat immunodeficiency and autoimmune disease. Due to its proven efficacy, it is the preferred choice of healthcare providers to treat various disorders like neurological disorders, infectious diseases, and autoimmune diseases. On the other hand, the coagulation factors segment is projected to expand at a significant rate in the coming years due to the growing prevalence of bleeding disorders like hemophilia.
• Based on application, the hemophil segment led the market with the largest share in 2024. Patients with hemophilia often lack sufficient clotting factors. However, plasma therapy provides essential proteins, increasing the ability to fight against condition. Meanwhile, the primary immunodeficiency diseases segment is projected to grow at a rapid pace in the upcoming period. The growing geriatric population is likely to contributes to segmental growth.

Regional Insights

North America held the largest share of the plasma therapeutics market in 2024. This is mainly due to its well-established developed healthcare and biopharmaceutical industries, public and private investment in R&D, and a larger number of plasma collection centers. There is a high demand for personalized medicine, opening up new avenues for plasma therapies.

On the other hand, Asia Pacific is expected to expand at the rate in the coming years. This is mainly due to the rising healthcare spending and increasing prevalence of various diseases, including bleeding disorders.  An aging population in countries like India and Japan and rising development of new therapeutics support regional market growth.

Plasma Therapeutics Market Coverage

Recent Development

• In June 2024, a Bengaluru-based Plasmagen Biosciences Private Limited launched Haemocomplettan P for the treatment of blood clotting during cardiac and liver transplant surgeries. Haemocomplettan P is a human fibrinogen concentrate, a specific protein derived from human plasma.
  (Source: https://health.economictimes.indiatimes.com)

Plasma Therapeutics Market Key Players

• ADMA Biologics Inc.
• Bio Products Laboratory Ltd.
• BIOPHARMA PLASMA
• CSL Ltd.
• Emergent BioSolutions Inc.
• Evolve Biologics Inc.
• Grifols SA
• Kamada Ltd.
• Kedrion Spa
• Octapharma AG
• Pfizer Inc.
• Prothya Biosolutions Netherlands BV
• SK Inc.
• Takeda Pharmaceutical Co. Ltd.

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/6236

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com|+1 804 441 9344